human
-
What's the connection between Huntington's Disease and cancer?
6 min read
HD patients are less likely to get cancer, according to a study from Sweden – what does this mean?
-
Huntexil update: EMA asks for further trial
2 min read
European Medicines Agency (EMA) tells NeuroSearch a European license for Huntexil in HD requires another large trial
-
Improving Huntington's disease clinical trial recruitment through patient and family education
5 min read
How can we improve recruitment into Huntington's disease clinical trials? Talking directly with families works!
-
The genetic 'gray area' of Huntington's disease: what does it all mean?
8 min read
Intermediate alleles and reduced penetrance ā the genetic 'gray area' of Huntingtonās disease, explained
-
Dimebon fails in late-stage human HD clinical trial
3 min read
Dimebon fails to improve symptoms in HD patients in the HORIZON trial
-
FDA: further trial needed for Huntexil approval in HD
2 min read
Bad news for Huntexil ā the FDA requires another trial before it can be approved in the US
-
Successful gene therapy trial in Parkinsonās Disease gives hope for HD
5 min read
Success for brain āgene therapyā in Parkinsonās disease ā good news for similar treatments being developed in HD
-
An active lifestyle may make a difference to HD symptoms
4 min read
More reasons to be active: a passive lifestyle may contribute to earlier onset of symptoms in HD.
-
Dimebon: disappointing in Alzheimerās but might work in HD
3 min read
Dimebon ā disappointing results in an Alzheimerās disease trial, but hope remains for HD.
-
Does HD cause brains to develop differently?
4 min read
Smaller total brain volumes in male HD mutation carriers suggests brain development may be different in HD.